Ahmed Raheel, Ghoorah Kuldeepa, Kunadian Vijay
From the *Faculty of Medical Sciences, Newcastle University Medical School, Newcastle, UK; †Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundations Trust, Newcastle, UK; and ‡Faculty of Medical Sciences, Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
Cardiol Rev. 2016 Mar-Apr;24(2):88-93. doi: 10.1097/CRD.0000000000000052.
An abdominal aortic aneurysm (AAA) is a focal full thickness dilatation of the abdominal aorta, greater than 1.5 times its normal diameter. Although some patients with AAA experience back or abdominal pain, most remain asymptomatic until rupture. The prognosis after AAA rupture is poor. Management strategies for patients with asymptomatic AAAs include risk factor reduction, such as smoking cessation, optimizing antihypertensive treatment, and treating dyslipidemia, as well as surveillance by ultrasound. Currently, aneurysm diameter alone is often used to assess risk of rupture. Once the aneurysm diameter reaches 5.5 cm, the risk of rupture is considered greater than the risk of intervention and elective aneurysm repair is undertaken. There is increasing interest in detecting AAAs early, and national screening programs are now in place. Furthermore, there is increasing research interest in biomarkers, genetics, and functional imaging to improve detection of AAAs at risk of progression and rupture. In this review, we discuss risk factors for AAA rupture, which should be considered during the management process, to advance current deficiencies in management pathways.
腹主动脉瘤(AAA)是腹主动脉的局限性全层扩张,其直径大于正常直径的1.5倍。虽然一些腹主动脉瘤患者会出现背部或腹部疼痛,但大多数患者在破裂前仍无症状。腹主动脉瘤破裂后的预后很差。无症状腹主动脉瘤患者的管理策略包括降低风险因素,如戒烟、优化降压治疗和治疗血脂异常,以及通过超声进行监测。目前,通常仅用动脉瘤直径来评估破裂风险。一旦动脉瘤直径达到5.5厘米,破裂风险被认为大于干预风险,就会进行择期动脉瘤修复。早期检测腹主动脉瘤的兴趣日益浓厚,国家筛查项目现已实施。此外,对生物标志物、遗传学和功能成像的研究兴趣也在增加,以改善对有进展和破裂风险的腹主动脉瘤的检测。在本综述中,我们讨论腹主动脉瘤破裂的风险因素,在管理过程中应予以考虑,以改善当前管理途径中的不足。